middle aged

中老年人
  • DOI:
    文章类型: Journal Article
    本文的目的是报告2例非手术牙髓治疗与大皮质骨穿孔相关的根尖周病变,并回顾有关非手术牙髓治疗的临床疗效的文献,以从已发表的病例报告中获得见解。大,2例囊肿样根尖周病变采用根管联合治疗方法成功治疗,抗菌治疗(氢氧化钙和三重抗生素糊剂[TAP]),和运河空间的矿物三氧化物聚集体(MTA)闭塞。在这两种情况下,器械延伸超过根尖孔1毫米,以促进通过根管引流。因为据推测根尖周病变可能是囊性的。仪表之后,将TAP放置在管道空间内,以帮助牙齿的消毒和愈合,牙髓,和根尖条件。在这两个病人中,牙齿在随访检查时无症状且具有功能性(病例1,3年;病例2,30个月).支持2例临床病例的积极结果,已发表的文献表明,使用生物相容性材料,如MTA,可以促进羟基磷灰石的沉积,有可能促进组织再生和大的根尖周病变的愈合。
    The objectives of this article are to report 2 cases of nonsurgical endodontic treatment for the management of periapical lesions associated with large cortical bone perforations and review the literature on the clinical efficacy of nonsurgical endodontic treatment to draw insights from published case reports. Large, cyst-like periapical lesions in 2 patients were successfully treated with combined modalities of root canal treatment, antimicrobial therapy (calcium hydroxide and triple antibiotic paste [TAP]), and mineral trioxide aggregate (MTA) obturation of the canal space. In both cases, instrumentation was extended 1 mm beyond the apical foramen to facilitate drainage through the root canal, because it was assumed that the periapical lesion could be cystic. After instrumentation, TAP was placed within the canal space to aid in disinfection and healing of the dental, pulpal, and periapical conditions. In both patients, the teeth were asymptomatic and functional at follow-up examinations (case 1, 3 years; case 2, 30 months). Supporting the positive outcomes in the 2 clinical cases, the published literature suggests that the use of biocompatible materials such as MTA, which can promote the deposition of hydroxyapatite, has the potential to contribute to tissue regeneration and the healing of large periapical lesions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    线性扁平苔藓是扁平苔藓的一种罕见变体,表现为瘙痒,多边形,紫色的丘疹在胚齿状的分布。这篇综述严格评估了所有报告的线性扁平苔藓(LLP)的病因。临床和组织学特征,治疗方案,和复发。从一开始到2023年3月的PubMed搜索,然后是文章筛选和全文审查,确定了51例独特的LLP病例。每个病例的数据包括患者的性别,病变的解剖分布,活检结果,提出的病因,治疗,并记录复发。LLP没有表现出明显的性别或年龄倾向,最常见的是单侧瘙痒,涉及许多解剖区域。各种触发器,包括金属植入物,疫苗接种,感染,恶性肿瘤,并确认怀孕。最常见的组织病理学描述包括带状淋巴细胞或苔藓样浸润,基底液化,空泡变性,高颗粒症,角化过度,陶器或胶体体,黑色素失禁,和角膜塑形。治疗方案,治疗持续时间,LLP病变的复发率是可变的。虽然LLP很少见,皮肤科医生应该意识到这种情况以及适当的诊断和治疗选择,因为快速诊断可以降低患者的发病率。
    UNASSIGNED: Lichen linear planus is a rare variant of lichen planus that appears as pruritic, polygonal, purple papules in a blaschkoid distribution. This review critically assesses all reported cases of linear lichen planus (LLP) for proposed etiology, clinical and histologic traits, treatment options, and recurrence. A PubMed search from inception through March 2023, followed by article screening and full-text review, identified 51 unique cases of LLP. Data from each case including the sex of the patient, anatomic distribution of lesions, biopsy results, proposed etiology, treatment, and recurrence were recorded. LLP did not show a significant gender or age predilection, most frequently presented unilaterally with pruritus, and involved numerous anatomic regions. Various triggers including metal implants, vaccinations, infections, malignancy, and pregnancy were identified. The most common histopathologic descriptions included band-like lymphocytic or lichenoid infiltrate, basal liquefactive, vacuolar degeneration, hypergranulosis, hyperkeratosis, civatte or colloid bodies, melanin incontinence, and orthokeratosis. Treatment options, duration of treatment, and recurrence rate of LLP lesions were variable. Although LLP is rare, dermatologists should be aware of this presentation and appropriate diagnostic and treatment options because swift diagnosis can reduce patient morbidity.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    Efgartigimod(Efgartigimodalphafcab,Vyvgart™)是一种开创性的新生儿Fc受体(FcRn)拮抗剂,用于治疗由致病性免疫球蛋白G(IgG)自身抗体介导的严重自身免疫性疾病,包括重症肌无力(MG)。这是一种耐受性良好的药物,副作用小,如头痛和上呼吸道(肺)和尿路感染。这里,我们介绍了一例60岁的眼MG(OMG)患者的卡波西水痘样喷发(KVE)和与efgartigimod相关的疱疹性结膜炎。
    一名60岁的中国男性患有乙酰胆碱受体抗体阳性(AChRAb+)OMG8年。在此期间,他接受了全身性皮质类固醇的一线治疗,环孢菌素,环磷酰胺,等等,但症状改善不佳。根据他的主治神经科医生的建议,他接受了一个周期的静脉注射efgartigimod(10mg/kg,每周一次,共4周)。病人发烧,广泛的痛苦的水泡,最后一次静脉输液后的第三天面部浮肿。患者还抱怨双眼分泌物增加和异物感。实验室检查证实感染单纯疱疹病毒(HSV)。诊断为efargisimod相关的KVE和疱疹性结膜炎。静脉给药后(5mg/kg,一天三次,每8小时)10天,患者治愈,无残余并发症。
    该病例是PubMed中首次报告的KVE和与efgartigimod相关的疱疹性结膜炎患者。这是罕见和不寻常的。临床医生应警惕与efgartigimod相关的罕见症状。
    UNASSIGNED: Efgartigimod (Efgartigimod alpha fcab, Vyvgart™) is a pioneering neonatal Fc receptor (FcRn) antagonist for the treatment of severe autoimmune diseases mediated by pathogenic immunoglobulin G (IgG) autoantibodies, including myasthenia gravis (MG). It is a well-tolerated drug with minor side effects, such as headache and upper respiratory (lung) and urinary tract infections. Here, we present a case of Kaposi\'s varicelliform eruption (KVE) and herpetic conjunctivitis related to efgartigimod in a 60-year-old patient with ocular MG (OMG).
    UNASSIGNED: A 60-year-old Chinese male suffered from acetylcholine receptor antibody positive (AChR Ab+) OMG for 8 years. During this period, he underwent first-line treatment with systemic corticosteroids, cyclosporine, cyclophosphamide, and so on, but had poor symptom improvement. On the recommendation of his attending neurologist, he received one cycle of intravenous efgartigimod (10mg/kg, once weekly for 4 weeks). The patient experienced fever, widespread painful blisters, and edema on the face on the third day after his last intravenous infusion. The patient also complained of increased secretions and a foreign body sensation in both eyes. Laboratory tests confirmed infection with herpes simplex virus (HSV). A diagnosis of efgartigimod-associated KVE and herpetic conjunctivitis was made. After intravenous administration (5mg/kg, 3 times a day, every 8 hours) for 10 days, the patient was cured without residual complications.
    UNASSIGNED: This case is the first report of a patient with KVE and herpetic conjunctivitis related to efgartigimod in PubMed. This is rare and unusual. Clinicians should be alert to the rare symptoms related to efgartigimod.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    背景:Lennert淋巴瘤(LL)是外周T细胞淋巴瘤的一种变体,未指定(PTCL,NOS),也被称为PTCL的淋巴上皮样变体。由于罕见且缺乏明确的诊断标准,LL是敏感的诊断。尽管先前诊断为LL可能会随着分子和/或遗传发现的出现而重新分类和评估,细胞形态学和免疫组织化学仍然是引起正确诊断的关键。
    方法:我们报告一例患者,根据细胞形态学和免疫组织化学诊断为LL。常规染色(Hematoxlin和Eosin-H&E)显示肿瘤细胞主要为小至中等大小的CD4(+)T细胞,CD8+/TIA-1+细胞毒性细胞较少,滤泡辅助性T细胞标志物(CD10,BCL6,PD1,CXCL13,ICOS)或CD21(+)增生性FDC网络无表达,或高内皮小静脉的增殖被注意到;然而,背景中注意到许多上皮样组织细胞,并且还存在分散的EBV(+)细胞。患者在环磷酰胺化疗6个疗程后达到完全缓解,表柔比星,长春新碱,依托泊苷,和泼尼松方案。随访5年,无复发或进展。
    结论:经典LL不难通过细胞形态学和免疫组织化学来诊断,突变谱有助于区分LL和其他淋巴瘤。
    BACKGROUND: Lennert lymphoma (LL) is a variant of peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS), also known as a lymphoepithelioid variant of PTCL. Because of the rarity and lack of clear-cut diagnostic criteria, LL is susceptible tomisdiagnosis. Although previously diagnosed with LL might be reclassified and evaluated with the advent of of molecular and/or genetic findings, cytomorphology and immunohistochemistry are still the key to give rise to correct diagnosis.
    METHODS: We report a case of a patient who was diagnosed as LL based on cytomorphology and immunohistochemistry. Routine stain (Hematoxlin and Eosin-H&E) revealed tumor cells were mainly small to medium-sized CD4(+) T cells, the CD8 +/TIA-1 + cytotoxic cells were less minority, no expressions of follicle helper T cell markers (CD10, BCL6, PD1, CXCL13, ICOS) or CD21(+) hyperplastic FDC network, or proliferation of high edndothelial venules were noted; however, numerous epithelioid histiocytes are noted in the background and scattered EBV(+) cells were also present. The patient was achieved complete remission after six courses of chemotherapy with cyclophosphamide, epirubicin, vincristine, etoposide, and prednisone regimen. She was followed for 5 years without recurrence or progression.
    CONCLUSIONS: Classic LL is not difficult to diagnose by cytomorphology and immunohistochemistry, and the mutation profiles can be helpful to distinguish LL from other lymphomas.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    Multiple primary lung cancer (MPLC) refers to patients with two or more primary lesions of lung cancer. It can be divided into synchronous MPLC (sMPLC) and metachronous MPLC (mMPLC) based on the timing of occurrence. In recent years, the detection rate of MPLC has gradually increased. However, considerable controversy exists in distinguishing MPLC from intrapulmonary metastasis (IM), especially when the histopathological types are identical. Given the significant differences in treatment strategies and prognosis in clinical practice currently, accurate diagnosis of MPLC is crucial for personalized precision therapy. Molecular genetics and sequencing technologies offer effective strategies for assessing the clonal origin of tumors. There have been reports of coexisting mutations in the epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) fusion genes in non-small cell lung cancer, but case of EGFR mutation following an ALK mutation has not been mentioned. This article accurately diagnoses and retrospectively analyzes the clinical data of a case of ALK mutant adenocarcinoma in a male patient who developed an EGFR mutation with multiple metastases four years after surgery, and reviews the relevant literature. This paper aims to deepen the understanding of mMPLC and provide clinical references for the diagnosis and treatment of such patients.
.
    【中文题目:EGFR和ALK基因异时性突变非小细胞肺癌
1例报告并文献复习】 【中文摘要:多原发肺癌(multiple primary lung cancer, MPLC)指患者有两个或两个以上原发病灶的肺癌,根据发生时间的不同分为同时性多原发肺癌(synchronous MPLC, sMPLC)和异时性多原发肺癌(metachronous MPLC, mMPLC)。近年来,MPLC的检出率逐渐升高,但由于肿瘤的异质性,在鉴别MPLC和肺内转移(intrapulmonary metastasis, IM)上存在许多争议,特别是病理组织学类型相同时。考虑到目前二者在临床治疗策略及预后上的显著差异,对于MPLC和IM的精确诊断是个体化精准治疗的关键。分子遗传学及测序技术为检测肿瘤的克隆性起源提供了有效的策略,其中非小细胞肺癌表皮生长因子受体(epidermal growth factor receptor, EGFR)突变与间变性淋巴瘤激酶(anaplastic lymphoma kinase, ALK)融合突变共存的病例陆续有报道,但ALK基因突变后再发EGFR突变的案例未见提及。本文通过分子遗传学技术准确诊断并回顾性分析了1例ALK突变型男性肺腺癌患者术后4年再发EGFR突变合并多发转移的临床资料,并复习相关文献,以期加深对mMPLC的认识,为该类病例的诊疗提供临床借鉴。
】 【中文关键词:异时性多原发肺癌;肺内转移;EGFR;ALK】.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    方法:我们介绍了一个45岁男子的独特案例,他的右手中指嵌有戒指。由于嵌入环通过关节的背侧迁移引起的屈肌腱损伤,注意到手指屈曲有限。这些环在麻醉下被移除,导致骨结构的肿胀和恢复的分辨率。随访检查发现没有残留水肿或麻木,显示保留的神经血管形成,尽管环的背侧迁移。
    结论:我们独特的案例显示连续的指环迁移而不损害神经血管束,回顾了30例强调精神病咨询的重要性的病例。及时的干预使近一半的患者实现了完全康复。
    METHODS: We present a unique case of a 45-year-old man with his right middle finger embedded with rings. Limited finger flexion was noted because of flexor tendon injury caused by the dorsal migration of the embedded ring through joint. The rings were removed under anesthesia, resulting in the resolution of swelling and recover of osseous structure. Follow-up examinations revealed no residual edema or numbness, indicating preserved neurovascularization, despite the dorsal migration of the ring.
    CONCLUSIONS: Our unique case reveals continuous finger ring migration without compromising neurovascular bundles, with review of 30 cases emphasizing the importance of psychiatric consultation. Timely intervention yielded nearly half of patients achieving full recovery.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:与原发性乳腺肉瘤(BS)相比,放疗诱导的肉瘤(RIS)是一种不太常见的继发性乳腺肉瘤。未分化多形性肉瘤(UPS)在RIS类别中更为罕见。本研究旨在介绍乳腺放疗诱导UPS的临床病理和分子特征。
    方法:苏州大学附属第三医院进行回顾性研究,分析3例乳腺癌后放射性未分化多形性肉瘤(UPS)患者,从2006年到2023年。从病历中提取临床和病理变量,而免疫组织化学用于分析这些肿瘤的免疫表型。通过DNA和RNA测序技术评估基因组特征。还回顾了文献中的另外15例病例,以更好地表征肿瘤。
    结果:受影响的区域包括胸壁和乳房,潜伏期从6年到17年不等。肿瘤细胞表现出多态性,并表现出高度的病理性有丝分裂。值得注意的是,两个病例显示疾病进展加速,以最初诊断后分别在48个月和7个月内发生的复发肿瘤和转移为特征。两个主要的鉴定基因是TP53(2/3,66.7%)和RB1(1/3,33.3%)。通过分析体细胞拷贝数变异(CNV),发现了两个癌基因,MCL1(1/3,33.3%)和MYC(1/3,33.3%),经历了CNV的增长。病例1、病例2和病例3的肿瘤突变负担(TMB)值为5.9mut/Mb,1.0mut/Mb,和3.0mut/Mb,分别。此外,RNA-NGS(下一代测序)的分析揭示了一种新的基因融合的存在,命名为COL3A1-GULP1,在情况2。
    结论:根据我们对研究结果和以前报告的全面分析,很明显,放射疗法诱导的UPS表现出高度多样且经常严重的临床和生物学行为。使用基因组测序识别肿瘤形成可以帮助了解其生物学行为并确定个性化治疗。
    OBJECTIVE: Compared to primary breast sarcoma (BSs), radiotherapy-induced sarcoma (RIS) is a less frequent type of secondary breast sarcoma. Undifferentiated pleomorphic sarcoma (UPS) is an even rarer occurrence within the RIS category. This study aimed to present the clinicopathologic and molecular features of breast radiotherapy-induced UPS.
    METHODS: A retrospective study was conducted at the Third Affiliated Hospital of Soochow University to analyze three patients with radiation-induced undifferentiated pleomorphic sarcoma (UPS) following breast cancer, spanning from 2006 to 2023. The clinical and pathological variables were extracted from the medical records, while immunohistochemistry was employed to analyze the immunophenotypes of these tumors. Genomic characteristics were assessed through DNA and RNA sequencing techniques. Another 15 cases from the literature were also reviewed to better characterize the tumor.
    RESULTS: The affected areas encompass the chest wall and breasts, with an incubation period ranging from 6 to 17 years. The tumor cells exhibit pleomorphism and demonstrate a high degree of pathological mitosis. Notably, two cases displayed an accelerated disease progression, characterized by recurrent tumors and metastases occurring within short intervals of 48 and 7 months respectively subsequent to the initial diagnosis. The two prevailing identified genes were TP53 (2/3, 66.7%) and RB1 (1/3, 33.3%). Through analysis of somatic copy number variation (CNV), it was discovered that two oncogenes, MCL1 (1/3, 33.3%) and MYC (1/3, 33.3%), had experienced gains in CNV. The Tumor Mutational Burden (TMB) values for case 1, case 2, and case 3 were 5.9 mut/Mb, 1.0 mut/Mb, and 3.0 mut/Mb, respectively. Moreover, the analysis of RNA-NGS (next-generation sequencing) revealed the presence of a novel gene fusion, named COL3A1-GULP1, in case 2.
    CONCLUSIONS: Based on our thorough analysis of research findings and previous reports, it is evident that radiotherapy-induced UPS exhibits a highly diverse and frequently severe clinical and biological behavior. Identifying tumor formation using genome sequencing can help understand its biological behavior and determine personalized treatments.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:有组织的乳腺癌筛查(BCS)计划是50-69岁女性预防德国第六大死亡原因的有效措施。尽管国家筛查计划的实施始于2005年,但参与率尚未达到欧盟标准。目前尚不清楚哪些社会人口统计学因素以及如何与BCS出勤率相关。这项范围审查旨在确定在德国实施有组织的筛查计划后,50-69岁女性在BCS出勤率方面的社会人口统计学不平等。
    方法:遵循PRISMA指南,我们搜索了科学网,Scopus,MEDLINE,PsycINFO,跟随PCC的CINAHL(人口,概念和上下文)标准。我们纳入了定量研究设计的主要研究,并审查了50-69岁女性的BCS出勤率,并收集了2005年以来德国的数据。制定了收获图,描绘了不同的社会人口统计学不平等以及最近两年或更少的BCS出勤率和终身BCS出勤率的影响大小方向。
    结果:我们筛选了476篇标题和摘要以及33篇全文。总的来说,分析了27条记录,14是国家报告,和13篇同行评议的文章。在收获地块中确定并总结了八个社会人口统计学变量:年龄,教育,收入,迁移状态,区的类型,就业状况,合伙同居和健康保险。生活在农村地区且缺乏私人保险的低收入和移民背景的老年妇女对BCS邀请的反应更积极。然而,从一生的角度来看,这些协会只适用于移民背景,在收入和城市居住权方面被逆转,并辅以伴侣同居。最后,生活在前东德萨克森州的妇女,梅克伦堡-西波美拉尼亚,萨克森-安哈尔特,和图林根,以及前西德下萨克森州,在过去两年中,BCS出勤率较高。
    结论:需要高质量的研究来确定在德国没有参加BCS的风险较高的女性,以解决现有研究的高异质性,特别是因为整体出勤率仍然低于欧洲标准。
    背景:https://osf.io/x79tq/。
    BACKGROUND: Organized breast cancer screening (BCS) programs are effective measures among women aged 50-69 for preventing the sixth cause of death in Germany. Although the implementation of the national screening program started in 2005, participation rates have not yet reached EU standards. It is unclear which and how sociodemographic factors are related to BCS attendance. This scoping review aims to identify sociodemographic inequalities in BCS attendance among 50-69-year-old women following the implementation of the Organized Screening Program in Germany.
    METHODS: Following PRISMA guidelines, we searched the Web of Science, Scopus, MEDLINE, PsycINFO, and CINAHL following the PCC (Population, Concept and Context) criteria. We included primary studies with a quantitative study design and reviews examining BCS attendance among women aged 50-69 with data from 2005 onwards in Germany. Harvest plots depicting effect size direction for the different identified sociodemographic inequalities and last two years or less BCS attendance and lifetime BCS attendance were developed.
    RESULTS: We screened 476 titles and abstracts and 33 full texts. In total, 27 records were analysed, 14 were national reports, and 13 peer-reviewed articles. Eight sociodemographic variables were identified and summarised in harvest plots: age, education, income, migration status, type of district, employment status, partnership cohabitation and health insurance. Older women with lower incomes and migration backgrounds who live in rural areas and lack private insurance respond more favourably to BCS invitations. However, from a lifetime perspective, these associations only hold for migration background, are reversed for income and urban residency, and are complemented by partner cohabitation. Finally, women living in the former East German states of Saxony, Mecklenburg-Western Pomerania, Saxony-Anhalt, and Thuringia, as well as in the former West German state of Lower Saxony, showed higher BCS attendance rates in the last two years.
    CONCLUSIONS: High-quality research is needed to identify women at higher risk of not attending BCS in Germany to address the existing research\'s high heterogeneity, particularly since the overall attendance rate still falls below European standards.
    BACKGROUND: https://osf.io/x79tq/ .
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Systematic Review
    背景:经支气管肺冷冻活检(TBLC)是外科肺活检的替代方法,用于对不可分类的间质性肺病(ILD)或低置信度诊断的ILD进行组织病理学评估。这项荟萃分析综合了当前有关冷冻活检诊断性能和安全性的文献,侧重于程序和抽样技术。
    方法:Medline和Embase于2022年4月11日检索。研究包括患有不可分类ILD的成年人,报告诊断产量,TBLC的并发症和方法学技术。对诊断率进行了荟萃分析,气胸和出血。亚组分析和荟萃回归评估方法学变量。PROSPERO注册:CRD420223212386。
    结果:70项研究纳入6183名参与者。TBLC的诊断率为81%(95%CI79-83%,I2=97%),在全身麻醉下观察到更好的产量(p=0.007),冷冻活检前的ILD多学科会议(p=0.02),2.4mm冷冻探头(p=0.04),较高的平均强制肺活量(p=0.046)和较高的一氧化碳平均扩散能力(p=0.023)。气胸率为5%(95%CI4-5%,I2=91%),与2.4毫米冷冻探针相关的更高速率(p<0.00001),常规术后成像(p<0.00001),多瓣采样(p<0.0001),降低一氧化碳(p=0.028)和全身麻醉(p=0.05)的平均扩散能力。中度至重度出血率为12%(11-14%,I2=95%)和更高的比率与2.4mm冷冻探针(p=0.001)和出血评分选择(p=0.04)相关。
    结论:患者特征和可改变的因素,包括手术方法和麻醉技术,影响不可分类ILD患者TBLC的诊断产量和安全性结局,并导致临床结局的异质性.在制定个性化临床决策和指南时,应考虑这些变量,并在未来的研究中进行常规报告。
    BACKGROUND: Transbronchial lung cryobiopsy (TBLC) is an alternative to surgical lung biopsy for histopathological evaluation of unclassifiable interstitial lung disease (ILD) or ILD diagnosed with low confidence. This meta-analysis synthesised current literature regarding cryobiopsy diagnostic performance and safety, focusing on procedural and sampling techniques.
    METHODS: Medline and Embase were searched on 11 April 2022. Studies included adults with unclassifiable ILD, reporting diagnostic yield, complications and methodological techniques of TBLC. Meta-analyses were performed for diagnostic yield, pneumothorax and bleeding. Subgroup analyses and meta-regression assessed methodological variables. PROSPERO registration: CRD42022312386.
    RESULTS: 70 studies were included with 6183 participants. Diagnostic yield of TBLC was 81% (95% CI 79-83%, I2=97%), with better yield being observed with general anaesthesia (p=0.007), ILD multidisciplinary meeting prior to cryobiopsy (p=0.02), 2.4 mm cryoprobe (p=0.04), higher mean forced vital capacity (p=0.046) and higher mean diffusing capacity for carbon monoxide (p=0.023). Pneumothorax rate was 5% (95% CI 4-5%, I2=91%), with higher rates associated with a 2.4 mm cryoprobe (p<0.00001), routine post-procedure imaging (p<0.00001), multiple lobe sampling (p<0.0001), reduced mean diffusing capacity for carbon monoxide (p=0.028) and general anaesthesia (p=0.05). Moderate-to-severe bleeding rate was 12% (11-14%, I2=95%) and higher rates were associated with a 2.4 mm cryoprobe (p=0.001) and bleeding score selection (p=0.04).
    CONCLUSIONS: Patient characteristics and modifiable factors, including procedural methods and anaesthetic techniques, impacted diagnostic yield and safety outcomes of TBLC in people with unclassifiable ILD and contributed to heterogeneity of clinical outcomes. These variables should be considered for individualised clinical decision making and guideline development and warrant routine reporting in future research.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号